@article{vendrely:hal-04163679,
TITLE = {Panitumumab in combination with chemoradiotherapy for the treatment of locally-advanced anal canal carcinoma: Results of the FFCD 0904 phase II trial},
AUTHOR = {Vendrely, V{\'e}ronique and Ronchin, Philippe and Minsat, Mathieu and Le Malicot, Karine and Lemanski, Claire and Mirabel, Xavier and Etienne, Pierre-Luc and Li{\`e}vre, Astrid and Darut-Jouve, Ariane and de la Fouchardi{\`e}re, Christelle and Giraud, Nicolas and Breysacher, Gilles and Argo-Leignel, Delphine and Thimonnier, Elsa and Magn{\'e},
Nicolas and Abdelghani, Meher Ben and Lepage, C{\^o}me and Aparicio, Thomas},
URL = {https://univ-rennes.hal.science/hal-04163679},
JOURNAL = {Radiotherapy \& Oncology},
PUBLISHER = {Elsevier},
VOLUME = {186},
PAGES = {109742},
YEAR = {2023},
MONTH = Sep, DOI = {10.1016/j.radonc.2023.109742},
KEYWORDS = {Anal cancer ; Chemoradiotherapy ; Epidermal growth factor receptor ; Immunotherapy ; Panitumumab ; Squamous cell carcinoma},
PDF = {https://univ-rennes.hal.science/hal-04163679/file/Vendrely%20et%20al.%20-%202023%20-%20Panitumumab%20in%20combination%20with%20chemoradiotherapy%20.pdf},
HAL_ID = {hal-04163679},
HAL_VERSION = {v1},
}